Philippe Robert Selected Research

tele-methylhistamine

1/2022	Cerebrospinal Fluid Histamine Levels in Healthy Children and Potential Implication for SIDS: Observational Study in a French Tertiary Care Hospital.
1/2017	Cerebrospinal fluid levels of orexin-A and histamine, and sleep profile within the Alzheimer process.
1/2017	Temporal Changes in the Cerebrospinal Fluid Level of Hypocretin-1 and Histamine in Narcolepsy.
10/2012	Normal cerebrospinal fluid histamine and tele-methylhistamine levels in hypersomnia conditions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philippe Robert Research Topics

Disease

35	Alzheimer Disease (Alzheimer's Disease) 02/2022 - 01/2002
15	Dementia (Dementias) 02/2022 - 01/2002
15	Neoplasms (Cancer) 01/2020 - 05/2002
14	Cognitive Dysfunction 02/2022 - 01/2012
7	Narcolepsy 01/2020 - 04/2008
6	Body Weight (Weight, Body) 10/2022 - 04/2009
5	Brain Neoplasms (Brain Tumor) 01/2020 - 06/2007
4	Cataplexy 01/2020 - 04/2008
4	Glioma (Gliomas) 01/2020 - 06/2007
4	Disorders of Excessive Somnolence (Hypersomnia) 01/2020 - 04/2008
3	Rupture 01/2021 - 10/2008
3	Synovitis 03/2011 - 01/2008
3	Infections 03/2011 - 07/2009
3	Infarction (Infarctions) 05/2008 - 04/2004
2	Renal Insufficiency (Renal Failure) 12/2021 - 01/2017
2	Neurocognitive Disorders (Clerambault Syndrome) 01/2021 - 11/2020
2	Mental Disorders (Mental Disorder) 01/2020 - 01/2016
2	Sleep Deprivation 01/2019 - 12/2010
2	Neoplasm Metastasis (Metastasis) 01/2019 - 12/2015
2	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 12/2015
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2016 - 01/2002
2	Sleepiness 12/2010 - 04/2008
2	Osteomyelitis 07/2009 - 07/2008
2	Myocardial Infarction 11/2006 - 04/2004
1	COVID-19 05/2022
1	Sudden Infant Death (SID) 01/2022
1	Atrophy 01/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2021
1	Substance-Related Disorders (Drug Abuse) 01/2019
1	Depressive Disorder (Melancholia) 01/2019
1	Anaphylaxis (Anaphylactic Shock) 07/2018
1	Overweight 07/2018
1	Cardiac Arrhythmias (Arrythmia) 12/2017
1	Chronic Renal Insufficiency 01/2017
1	Nervous System Diseases (Neurological Disorders) 01/2017
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2017
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2016
1	Mixed Dementias 01/2016

Drug/Important Bio-Agent (IBA)

22	Contrast MediaIBA 01/2020 - 05/2002
12	GadoliniumIBA 10/2022 - 11/2006
10	gadolinium 1,4,7,10- tetraazacyclododecane- N,N',N'',N'''- tetraacetateIBA 01/2020 - 06/2002
9	Histamine (Histamine Dihydrochloride)FDA Link 01/2022 - 04/2007
8	Biomarkers (Surrogate Marker)IBA 02/2022 - 01/2013
8	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 12/2013 - 08/2006
6	pitolisantIBA 01/2020 - 04/2007
6	Memantine (Namenda)FDA Link 02/2013 - 04/2008
5	gadopiclenolIBA 10/2022 - 01/2019
5	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2016
5	OrexinsIBA 01/2017 - 04/2008
4	A-factor (Streptomyces)IBA 01/2022 - 04/2009
4	tele-methylhistamineIBA 01/2022 - 10/2012
4	Pharmaceutical PreparationsIBA 12/2017 - 09/2012
4	IntegrinsIBA 01/2017 - 01/2013
3	gadobutrolIBA 10/2022 - 12/2015
3	Amyloid beta-PeptidesIBA 02/2022 - 07/2005
3	Peptides (Polypeptides)IBA 01/2021 - 04/2009
3	gadoterate meglumineIBA 01/2020 - 04/2004
3	ferric oxide (iron oxide)IBA 12/2013 - 08/2006
2	gadodiamide (Omniscan)FDA Link 10/2022 - 01/2017
2	Biological ProductsIBA 01/2022 - 06/2014
2	gadobenic acid (gadobenate dimeglumine)FDA Link 01/2022 - 01/2020
2	Antipsychotic Agents (Antipsychotics)IBA 04/2017 - 01/2016
2	CytokinesIBA 01/2016 - 09/2009
2	Freund's AdjuvantIBA 12/2013 - 09/2012
2	Gadolinium DTPA (Magnevist)FDA Link 01/2011 - 03/2004
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Adenine FDA LinkGeneric 12/2021
1	EpitopesIBA 01/2021
1	Histocompatibility Antigens (Histocompatibility Antigen)IBA 01/2021
1	Member 2 Protein Solute Carrier Family 44IBA 01/2021
1	AntigensIBA 01/2021
1	Histamine H3 Receptors (Histamine H3 Receptor)IBA 01/2020
1	SolutionsIBA 05/2019
1	Dopamine D3 ReceptorsIBA 01/2019
1	florbetapirIBA 01/2019
1	Dihydrotachysterol (AT 10)IBA 01/2019
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 01/2019
1	AcidsIBA 01/2019
1	Epinephrine (Adrenaline)FDA LinkGeneric 07/2018
1	3-(2-carboxyindol-3-yl)propionic acidIBA 12/2017
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 05/2017
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2017
1	HLA-DQB1 antigen (HLA DQB1)IBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 05/2016
1	AntibodiesIBA 01/2016
1	Hypnotics and Sedatives (Sedatives)IBA 01/2016
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2016

Therapy/Procedure

11	Therapeutics 01/2020 - 04/2008
6	Activities of Daily Living (ADL) 08/2020 - 01/2008
3	Injections 10/2022 - 04/2009
3	Cognitive Training 11/2020 - 01/2016
2	Ossicular Prosthesis (TORP) 01/2021 - 01/2016
2	Intravenous Injections 01/2020 - 01/2013
2	Self-Help Devices (Assistive Technology) 05/2019 - 01/2016
2	Intra-Articular Injections 03/2011 - 06/2010
2	Radiotherapy 01/2011 - 11/2010
1	Language Therapy (Language Training) 05/2022
1	Intramuscular Injections 07/2018
1	Long-Term Care 04/2017
1	Home Nursing (Nursing, Home) 01/2016